Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer
- 129 Downloads
To understand trends in the incidence and mortality of two human papillomavirus (HPV)-associated cancers, cervical and oropharyngeal cancer, in Massachusetts.
From 2004 to 2014, the Massachusetts Cancer Registry recorded 3,996 incident cases of oropharyngeal cancer and 2,193 incident cases of cervical cancer. Mortality data were obtained from the Massachusetts Registry of Vital Records and Statistics from 2008 to 2014. Rates were age-standardized to the 2000 U.S. population and trends were assessed using joinpoint regression.
While the incidence rate of cervical cancer (5.46 per 100,000) decreased by 2.41% annually (p = 0.004), the incidence rate of oropharyngeal cancer among males (7.85 per 100,000) increased by 2.82% annually (p = 0.0002). Mortality rates for both cancers decreased from 2008 to 2014 but were not statistically significant (cervical − 3.73% annually, p = 0.29; oropharyngeal − 1.94% annually, p = 0.44).
The rising incidence rate of oropharyngeal cancer in men and the decreasing, but relatively high, incidence rate of cervical cancer in women highlight the need for further screening and prevention by HPV vaccination in Massachusetts.
KeywordsCancer Cervical cancer Oropharyngeal cancer Human papillomavirus (HPV) Massachusetts Population Surveillance
We would like to thank Annie MacMillan and Richard Knowlton at the Massachusetts Cancer Registry and Susan Lett from the Division of Epidemiology and Immunization at the Massachusetts Department of Public Health for their help with this project. This journal article was supported by the Cooperative Agreement Number, NU58D006271, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. We would also like to acknowledge funding from the grants R25 CA 98566-10, T32 CA 009001-40, and T32 ES 007069.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Centers for Disease Control and Prevention HPV Cancer [online] (2016) https://www.cdc.gov/cancer/hpv/statistics/cases.htm. Accessed 22 Mar 2017
- 4.U.S. Department of Health and Human Services (DHHS) (2017) National Center for Health Statistics. The 2016 National Immunization Survey—Teen, Hyattsville: Centers for Disease Control and PreventionGoogle Scholar
- 5.United States Census Bureau. QuickFacts Massachusetts [online] (2016) https://www.census.gov/quickfacts/table/PST045216/25. Accessed 29 Mar 2017
- 6.North American Association of Central Cancer Registries (NAACCR). Certified Registries [online] (2016) https://www.naaccr.org/certified-registries/. Accessed 7 June 2017
- 7.Joinpoint Regression, Program, Version 18.104.22.168 - January 2017; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer InstituteGoogle Scholar
- 8.SAS 9.3. Cary, NC, USA: SAS Institute IncGoogle Scholar
- 9.Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data [online] (2015) https://www.cdc.gov/brfss/brfssprevalence/. Accessed 10 May 2017
- 10.National Institute on Alcohol Abuse and Alcoholism. Surveillance Report #102 Apparent Per Capita Alcohol Consumption: National, State, and Regional Trends, 1977–2013. https://pubs.niaaa.nih.gov/publications/surveillance102/tab4-3_13.htm. Accessed 17 May 2017
- 12.Centers for Disease Control and Prevention (1993–2015) Youth Risk Behavior Survey Questionnaire. http://www.cdc.gov/yrbs. Accessed 17 May 2017
- 14.SEER Cancer Stat Facts: Cervix Uteri Cancer. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/statfacts/html/cervix.html
- 15.Howlander N, Noone AM, Krapcho M et al (2016) SEER Cancer Statistics Review, 1975–2014, National Cancer Institute. Bethesda, MD. https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site April 2017
- 16.Centers for Disease Control and Prevention. Gynecologic Cancers: Cervical Cancer Rates by Race Ethnicity [online] (2017) https://www.cdc.gov/cancer/cervical/statistics/race.htm. Accessed 15 Jan 2018
- 17.Pytynia KB, Dahlstrom KR, Sturgis EM (2014) Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol 50(5):380–386. https://doi.org/10.1016/j.oraloncology.2013.12.019 CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Massachusetts Department of Public Health, Health Survey Program. Data Brief: Massachusetts Adolescent Health: Sexual Health, Experiences, and Behaviors (Spring 2016) http://www.mass.gov/eohhs/docs/dph/behavioral-risk/mass-adole-health-sexual-health.pdf. Accessed 17 May 2017
- 22.Lorch JH, Hanna GJ, Posner MR et al (2015) Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: the Dana Farber experience. Head Neck 38(S1):E1618–E1624Google Scholar
- 27.Massachusetts Department of Public Health. Massachusetts Comprehensive Cancer Prevention and Control Network (2017) http://www.mass.gov/eohhs/gov/departments/dph/programs/community-health/cancer-prev-and-control/program-structure.html. Accessed 19 July 2017
- 28.Wagner R, Villa A (2107) Oral human papillomavirus infections and the role of the dental professional. J Massachusetts Dent Soc 65(4):12–15Google Scholar
- 29.Massachusetts Cancer Registry, Massachusetts Department of Public Health (2018) http://www.mass.gov/dph/mcr. Accessed 12 Jan 2018